Development of vaginal spermicide and microbicide
Jacob, L.S.
AAAS Annual Meeting and Science Innovation Exposition 162: A152
1996
Document Number: 248410
Document emailed within 1 workday
Related Documents
Jacob, L.S. 1996: Development of vaginal spermicide and microbicide AAAS Annual Meeting and Science Innovation Exposition 162: A152Levin, R.J.; Parker, A.J. 1987: Spermicide action on the vagina effects of a new non surfactant spermicide rs 37367 on rat vaginal electrogenic ion transfer and permeability in vitro Medical Science Research 15(17): 1045-1046
Levin, R.J.; Parker, A.J. 1987: Spermicide action on the vagina effects of a new non surfactant spermicide rs 37367 on rat vaginal electrogenic ion transfer and permeability in vitro Medical Science Research 15(17): 1045-1046
Gupta, G. 2005: Microbicidal spermicide or spermicidal microbicide? European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 10(4): 212-218
Isaacs, C.E.; Pullarkat, R.; Kascsak, R. 2001: Development of a topical vaginal microbicide: lessons learned from human milk Advances in Experimental Medicine and Biology 501: 223-232
Murphy, D.J.; Desjardins, D.; Dereuddre-Bosquet, N.; Brochard, P.; Perrot, L.; Pruvost, A.; Le Grand, R.; Lagatie, O.; Vanhooren, L.; Feyaerts, M.; van Roey, J.; Malcolm, R.K. 2014: Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir Journal of Antimicrobial ChemoTherapy 69(9): 2477-2488
Mahan, E.D.; Morrow, K.M.; Hayes, J.E. 2011: Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development Contraception 84(2): 184-193
Johansson, E.D.; Maguire, R.A.; Phillips, D.M. 1999: Pushing the frontiers of science--the Population Council's Microbicide Basic Science Network on vaginal microbicide research International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 67 Suppl. 2: S117-S124
Joshi, S.; Joglekar, N.; Ghate, M.; Unni, J.; Risbud, A.; Bentley, M.; Shepherd, M.; Bollinger, R.; Mehendale, S. 2003: Phase i safety and preliminary acceptability of nonoxynol-9 vaginal pessary as a vaginal microbicide in low risk women in Pune, India Indian Journal of Medical Research 117: 152-157
Iyer, V.; Poddar, S.S. 2008: Update on nonoxynol-9 as vaginal spermicide European Journal of Contraception and Reproductive Health Care: the Official Journal of the European Society of Contraception 13(4): 339-350
Mauck, C.; Glover, L.H.; Miller, E.; Allen, S.; Archer, D.F.; Blumenthal, P.; Rosenzweig, A.; Dominik, R.; Sturgen, K.; Cooper, J.; Fingerhut, F.; Peacock, L.; Gabelnick, H.L. 1996: Lea's Shield: a study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide Contraception 53(6): 329-335
Clarke, J.G.; Peipert, J.F.; Hillier, S.L.; Heber, W.; Boardman, L.; Moench, T.R.; Mayer, K. 2002: Microflora changes with the use of a vaginal microbicide Sexually Transmitted Diseases 29(5): 288-293
Malcolm, R.K.; Edwards, K.-L.; Kiser, P.; Romano, J.; Smith, T.J. 2010: Advances in microbicide vaginal rings Antiviral Research 88(Suppl 1): S30-S39
Le Lannou, D.; Colleu, D.; Blanchard, D. 1988: Effets in vitro d'un spermicide vaginal, le nonoxynol 9 ou Patentex ovule - In vitro effects of vaginal spermicid: nonoxynol 9 or Patentex Contraception Fertilite Sexualite (1973) 16(1): 20-22
Janneke, H. H. M. van de Wijgert, G N. Khumalo-Sakutukwa, C Coggins, S E. Dube, P Nyamapfeni, M Mwale and Nancy, S. Padian 1999: Men's Attitudes Toward Vaginal Microbicides and Microbicide Trials in Zimbabwe International Family Planning Perspectives 25(1): 15-20
Barnhart, K.T.; Pretorius, E.S.; Shaunik, A.; Timbers, K.; Nasution, M.; Mauck, C. 2005: Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2.5 and 3.5 mL) Contraception 72(1): 65-70
Jespers, V.; Buvé, A.; Van Damme, L. 2007: Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men Sexually Transmitted Diseases 34(7): 519-522
Catalone, B.J.; Kish-Catalone, T.M.; Neely, E.B.; Budgeon, L.R.; Ferguson, M.L.; Stiller, C.; Miller, S.R.; Malamud, D.; Krebs, F.C.; Howett, M.K.; Wigdahl, B. 2005: Comparative safety evaluation of the candidate vaginal microbicide C31G Antimicrobial Agents and ChemoTherapy 49(4): 1509-1520
Tanner, A.E.; Katzenstein, J.M.; Zimet, G.D.; Cox, D.S.; Cox, A.D.; Fortenberry, J.Dennis. 2008: Vaginal microbicide preferences among midwestern urban adolescent women Journal of Adolescent Health: Official Publication of the Society for Adolescent Medicine 43(4): 349-356
Mayer, K.H.; Peipert, J.; Fleming, T.; Fullem, A.; Moench, T.; Cu-Uvin, S.; Bentley, M.; Chesney, M.; Rosenberg, Z. 2001: Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 32(3): 476-482